BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2131009)

  • 1. Drug-immunoglobulin conjugates as targeted therapeutic systems.
    Mitra AK; Ghosh MK
    Targeted Diagn Ther; 1990; 3():141-87. PubMed ID: 2131009
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoconjugates in drug delivery systems.
    Cannon JB; Hui HW
    Targeted Diagn Ther; 1990; 3():121-39. PubMed ID: 2131008
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress.
    Marcucci F; Lefoulon F
    Drug Discov Today; 2004 Mar; 9(5):219-28. PubMed ID: 14980540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Star-shaped immunoglobulin-containing HPMA-based conjugates with doxorubicin for cancer therapy.
    Etrych T; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2007 Sep; 122(1):31-8. PubMed ID: 17631976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordination conjugates of therapeutic proteins with drug carriers: a new approach for versatile advanced drug delivery.
    Kejík Z; Bříza T; Králová J; Poučková P; Král A; Martásek P; Král V
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5514-20. PubMed ID: 21784635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From monoclonal antibodies to immunonanospheres in the pharmaceutical sciences.
    Rolland AP; Bourel D
    Targeted Diagn Ther; 1990; 3():259-88. PubMed ID: 2131013
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of high molecular weight agents.
    Cassidy J; Newell DR; Wedge SR; Cummings J
    Cancer Surv; 1993; 17():315-41. PubMed ID: 8137346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies for treating and preventing disease: the potential role of polymeric controlled release.
    Saltzman WM
    Crit Rev Ther Drug Carrier Syst; 1993; 10(2):111-42. PubMed ID: 8370084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
    Doronina SO; Toki BE; Torgov MY; Mendelsohn BA; Cerveny CG; Chace DF; DeBlanc RL; Gearing RP; Bovee TD; Siegall CB; Francisco JA; Wahl AF; Meyer DL; Senter PD
    Nat Biotechnol; 2003 Jul; 21(7):778-84. PubMed ID: 12778055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy for brain tumours.
    Lesniak MS; Brem H
    Nat Rev Drug Discov; 2004 Jun; 3(6):499-508. PubMed ID: 15173839
    [No Abstract]   [Full Text] [Related]  

  • 15. Composite nanoparticles take aim at cancer.
    Gil PR; Parak WJ
    ACS Nano; 2008 Nov; 2(11):2200-5. PubMed ID: 19206383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transferrin conjugates in the anticancer therapy].
    Lubgan D; Marczak A; Distel L; Jóźwiak Z
    Postepy Biochem; 2006; 52(1):72-9. PubMed ID: 16869304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug delivery in cancer using liposomes.
    Dass CR
    Methods Mol Biol; 2008; 437():177-82. PubMed ID: 18369969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody targeted drugs as cancer therapeutics.
    Schrama D; Reisfeld RA; Becker JC
    Nat Rev Drug Discov; 2006 Feb; 5(2):147-59. PubMed ID: 16424916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cleavable molecular adapter reduces side effects and concomitantly enhances efficacy in tumor treatment by targeted toxins in mice.
    Fuchs H; Bachran C; Li T; Heisler I; Dürkop H; Sutherland M
    J Control Release; 2007 Feb; 117(3):342-50. PubMed ID: 17207883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted immunotherapy for malignant tumors].
    Turuo T
    Rinsho Ketsueki; 1999 Jun; 40(6):476-9. PubMed ID: 10422282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.